Associated Papers
Characterisation of pharmacogenomic variation in the Shetland and Orkney Isles in Scotland.
Twesigomwe D et al.
Scientific Reports, 2025
Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia.
Yaowaluk T et al.
European Journal of Clinical Pharmacology, 2022
A pilot study of assessing whole genome sequencing in newborn screening in unselected children in China.
Jian M et al.
Clinical and Translational Medicine, 2022
35665479 (PubMed )
Supplement: CTM2-12-e843-s002.xlsx › supplementary_table_10
Pharmacogenetics of healthy volunteers in Puerto Rico.
Claudio-Campos K et al.
Drug Metabolism and Personalized Therapy, 2015
A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.
Langaee T et al.
Plos One, 2015
The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.
Wakil SM et al.
Disease Markers, 2015
25802476 (PubMed )
Supplement: 542543.f1.xlsx › DMET_Suppl_data
Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.
Umamaheswaran G et al.
The Indian Journal of Medical Research, 2014
Genotype and phenotype concordance for pharmacogenetic tests through proficiency survey testing.
Wu AH
Archives of Pathology & Laboratory Medicine, 2013
Predicting drug response and toxicity based on gene polymorphisms.
Robert J et al.
Critical Reviews in Oncology/hematology, 2005
Select a paper to view details